Mayne Pharma may face disclosure breach claim over $672M merger collapse

M&A 2025-08-04 11:40 pm By Andy Sidler | Melbourne

A court has heard US drug maker Cosette may amend its case to accuse Adelaide’s Mayne Pharma of continuous disclosure breaches in their battle over the termination of their $672 million merger.